New factors in the regulation of adipose differentiation and metabolism

Current Opinion in Lipidology

Volumn 13, Issue 3, 2002, Pages 241-245

  Holst, Dorte ^a   Grimaldi, Paul A ^a  

^a CENTRE DE BIOCHIMIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT BINDING FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; ADIPONECTIN; CELL RECEPTOR; HORMONE; NERVE GROWTH FACTOR; PROTEIN; RESISTIN; RESISTIN LIKE ALPHA, MOUSE; RESISTIN-LIKE ALPHA, MOUSE; RETN PROTEIN, HUMAN; RETN PROTEIN, MOUSE; RETNLB PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIPID METABOLISM; LIPOATROPHY; MOLECULAR BIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; RISK ASSESSMENT; TISSUE DIFFERENTIATION; TRANSCRIPTION REGULATION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMAL; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HORMONES, ECTOPIC; HUMAN; INSULIN RESISTANCE; MICE; OBESITY; PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; ADIPONECTIN; ANIMALS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NERVE GROWTH FACTOR; RESISTIN;

EID: 0035985669     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200206000-00002     Document Type: Review

References (44)

1. Transcriptional regulation of adipogenesis
2. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation
3. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis
4. The roles of PPARs in adipocyte differentiation
5. Alterations of peroxisome proliferator-activated receptor delta activity affect fatty acid-controlled adipose differentiation
6. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)
7. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human pancreatic carcinoma cells
8. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer
9. Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1→S transition in vascular smooth muscle cells
10. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer
11. Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells
12. Peroxisome-proliferator-activated receptor delta mediates the effects of long-chain fatty acids on post-confluent cell proliferation
13. Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling
14. C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription
15. E2f repression by c/ebpalpha is required for adipogenesis and granulopoiesis in vivo
16. C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4
17. Function of GATA transcription factors in preadipocyte-adipocyte transition
18. Inhibition of adipogenesis by Wnt signaling
19. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance
20. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
21. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
22. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
23. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin
24. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys
25. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
26. Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24
27. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome
28. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
29. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
30. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
31. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
32. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls
33. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages
34. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages
35. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes
36. Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes
37. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein
38. The hormone resistin links obesity to diabetes
39. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation
40. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family
41. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists
42. Decreased resistin expression in mice with different sensitivities to a high-fat diet
43. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans
44. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle